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Gingival epithelial cells (GECs) represent a physical barrier against bacteria and are involved in the processes of innate immunity.
Recently, an anti-inflammatory and immune-modulatory effect of the amino acid glycine has been demonstrated. However, there is
only little information about the immune-modulatory effects of glycine in oral tissues.This study aimed to investigate the existence
and role of the glycine receptor in gingival tissue analyzing tissues/cells from extracted human molars via immunohistochemical
analysis. In vitro, GECs were challenged by inflammatory conditions with IL-1𝛽 alone or in combination with glycine and analyzed
for cytokine expression of IL6/IL8 via real-time PCR. On protein level, the effect of nuclear translocalization of NF𝜅B protein p65
was analyzed using immunofluorescence analysis. A distinct proof of the GlyR in oral gingival tissue and keratinocytes could be
demonstrated. Isolated challenge of the keratinocytes with IL-1𝛽 as well as with glycine resulted in an upregulation of IL6 and IL8
mRNA expression and activation of NF𝜅B pathway. The presence of glycine in combination with the inflammatory stimulus led to
a significant decrease in inflammatory parameters. These results indicate a possible anti-inflammatory role of glycine in gingival
inflammation and encourage further research on the utility of glycine in the prevention or therapy of inflammatory periodontitis.
1. Introduction
Periodontitis typically starts with inflammation of the gingiva
and proceeds by spreading into the deeper structures of
the periodontium, leading to progressive destruction of
periodontal tissues and the alveolar bone and to the loss
of teeth [1]. As a major part of the gingival tissue, gingival
keratinocytes represent a physical barrier to infections by
periodontal pathogens [2]. While the epithelium was previ-
ously thought to provide only a passive role in inflammation,
recent articles demonstrated a new perspective to inflamma-
tory conditions assigning an active role to the epithelium in
the host response to bacterial infections [3]. According to
these authors, the epithelium reacts to bacterial challenges
by signaling host defense and integrating innate and acquired
immune responses.
Signaling pathways of gingival keratinocytes that are
modulated by bacteria such as Porphyromonas gingivalis in
the course of periodontal infection include changes in intra-
cellular calcium ion (Ca2+) concentrations [4, 5]. Izutzu et al.
[4] demonstrated thatP. gingivalis invasion and inflammatory
response in human gingival epithelial cells is related to a
release of Ca2+ from intracellular reservoirs and subsequent
increase in cytosolic Ca2+. Contact between P. gingivalis
and epithelial cells is shown to activate the host-cell Ca2+
signaling system, a further sign for its inflammatory impact.
Similar inflammatory signaling is also reported for the
cytokine interleukin 1𝛽 (IL-1𝛽) which is involved in the
pathogenesis ofmany inflammatory diseases such as rheuma-
toid arthritis, inflammatory bowel disease, atherosclero-
sis, and also periodontitis [6–8]. In human keratinocytes,
induction of IL-1𝛽 was demonstrated to take place upon
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stimulation with bacterial lipopolysaccharide (LPS), phys-
ical or thermal injury, ultraviolet irradiation, and a vari-
ety of cytokines, that is, granulocyte-macrophage colony-
stimulating factor (GM-CSF), tumor necrosis factor-𝛼 (TNF-
𝛼), interleukin 6 (IL6), transforming growth factor-𝛽 (TGF-
𝛼), and IL-1𝛽 [6, 9]. IL-1𝛽 is reported to trigger chemotaxis
of neutrophil granulocytes as well as T and B cell activation.
In addition, it stimulates the expression of the early response
genes, multiple cytokines, and inflammatory factors that
drive extracellular matrix degradation [6, 7].
For an anti-inflammatory purpose, the use of glycine is
reported to induce beneficial immune-modulatory and cyto-
protective effects [10–12]. L-glycine is the smallest nonessen-
tial amino acid that consists of a methylene carbon molecule
attached to an amino- and a carboxyl group. In nonner-
vous tissue, glycine is considered to be biologically neutral.
In the last years, however, numerous investigations have
revealed significant effects of glycine on the activation of
cells belonging to the innate as well as the adaptive immune
system, including macrophages, polymorphonuclear neu-
trophils (PMNs), and lymphocytes [13–15]. In patient’s treat-
ment, glycine has been reported to have several benefi-
cial effects including protection against toxicity induced by
anoxia, oxidative stress, and various toxic agents at the cell,
tissue, and whole body levels [10, 12, 16]. For instance, it
was demonstrated that a diet enriched with glycine protected
against LPS-induced lethality, hypoxia-reperfusion injury
after liver transplantation, D-galactosamine-mediated liver
injury, and experimental arthritis [10–12, 17].
The glycine receptor (GlyR) is composed of four 48 kDa
𝛼-subunits and a 58 kDa 𝛽-subunit and comprises a pen-
tameric complex that forms a chloride-selective trans-mem-
brane channel [18]. In support of pharmacological evi-
dence for the existence of GlyR in nonneuronal cells stated
above, recent studies provide molecular evidence for the
GlyR in nonneuronal cells. A wide variety of cells such
as neutrophils, alveolar macrophages, endothelial cells, and
Kupffer cells have been shown to contain glycine-gated
chloride channels [10–12, 16]. In addition, Denda et al. [19]
demonstrated that the existence of the GlyR in epidermal
keratinocytes might play a crucial role in cutaneous barrier
homeostasis.
Several reports showed that glycine suppresses formation
of inflammatory cytokines [10–12]. As stated above, the pro-
duction of proinflammatory mediators induced by bacterial
LPS depends on the increase in intracellular Ca2+, an effect
that was demonstrated to be blunted after treatment with
glycine. The exact mechanism of how increased intracellular
calcium levels are blocked by glycine is not yet completely
understood.
In recent investigations, Breivik and coworkers [20]
pointed to the anti-inflammatory potential of glycine in oral
tissues. In their animal experiments, these authors were
able to demonstrate a significant reduction of artificially
induced periodontal infection following a specific glycine
diet. Substitution of glycine to animal’s food prevented
animals from severe periodontal breakdown. However, infor-
mation is missing whether glycine and its receptors may
be able to modulate the development of inflammatory oral
gingivitis and if they are able to protect oral tissues from
severe periodontal disease.
In this context, the first aim of the present study was
expression analysis of glycine receptors in gingival tissue and
further analysis of the glycine signaling role in oral gingival
keratinocytes.Wehypothesized that glycine receptors are also
expressed within the oral gingival tissue and that glycine
application might be able to modulate the inflammatory
response of gingival keratinocytes in inflammatory condi-
tions.
2. Material and Methods
All experimental protocols were reviewed and approved by
the Ethics Committee of the University of Bonn.
2.1. Human Gingival Tissue. Tissue samples from human
gingiva were obtained during routine extraction treatment
of third molars. Human gingiva samples were collected from
three different human donors aged between 12 and 14 years
showing no clinical signs of gingivitis and periodontitis. The
teeth had been extracted for orthodontic reasons and with
written parental consent. Following extraction, human teeth
including gingiva were perfused with phosphate-buffered
saline supplemented with 4% paraformaldehyde for fixation
purposes. Afterwards, the gingiva of each tooth was dissected
and prepared for light microscopical examination as recently
described [21, 22].
2.2. Histology. For histological analyses, all specimens were
processed for paraffin histology. To perform histology, 5–
7 𝜇m serial sagittal sections of each specimen were prepared.
For orientation purposes, selected sections were stained with
hematoxylin and eosin.
2.3. Immunohistochemistry. To analyze glycine receptor ex-
pression, tissue sections were processed for immunohisto-
chemical detection of glycine receptor expression according
to previously established protocols [22, 23]. In brief, sections
were incubated with primary antibody of rabbit origin raised
against a peptide mapping at the carboxy terminus of the
protein (anti-glycine receptor, SYSY, Go¨ttingen, Germany)
in a 1 : 250 working solution of TBS/BSA at 4∘C overnight
in a humidified chamber. A 1 : 100 dilution of a goat anti-
rabbit immunoglobulin (DakoA/S, Denmark) was incubated
as secondary antibody for 30min. Following further rinsing,
a PAP complex (1 : 150 in TBS/BSA; Dako A/S Denmark) was
administered for 30min prior to the visualization of anti-
body bindingwith 3,3󸀠-diaminobenzidine (SigmaChemicals,
USA) solution for about 5min. Thereafter, specimens were
counterstained with Mayer’s hematoxylin, dehydrated, and
cover-slipped for light microscopical analysis.
In order to prove the specificity of the immunoreactions,
negative controls were carried out by (a) omitting the primary
antibody or using nonimmune IgG instead and (b) omitting
both the primary and secondary antibody and using TBS/
BSA instead.
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Preadsorption controls were used to exclude unspecific
binding of the antibodies to unrelated antigens.The antibody
was combined with a twofold excess of blocking peptide
and incubated at 4∘C overnight. Following neutralization, the
antibody/peptide mixture was diluted into the appropriate
working solution. Afterwards, immunohistochemistry was
carried out as described above.
2.4. Explantation of Gingival Keratinocytes. Gingival ker-
atinocytes/epithelial cells (GECs) were cultured from gingiva
of three periodontal healthy patients as described above.
The cells were isolated by collagenase digestion and sub-
sequent mechanical isolation of the epithelial layer from
the connective tissue as described previously [24]. Follow-
ing explantation, cells were seeded on 60mm dishes and
cultured in KGM-Medium (Keratinocyte Growth Medium,
PromoCell, Heidelberg, Germany) supplemented with CaCl
2
(0.15mM) and 0.5% antibiotics (diluted from a stock solution
containing 5,000U/mL penicillin and 5,000U/mL strepto-
mycin; Biochrom AG, Germany) under a saturated humid-
ified atmosphere containing 5% CO
2
at 37∘C. The medium
was changed every other day. Prior to experimental use,
gingiva keratinocytes were characterized as described previ-
ously [24]. For cell culture experiments, cells were used in
passage 4.
2.5. Induction of Gingival Inflammation: In Vitro. To mimic
inflammatory impact on gingival keratinocytes similar to the
environment in gingivitis, cells were cultured in presence
of the amount of 5 ng/mL IL-1𝛽 (Promokine, Heidelberg,
Germany) as measured in patients suffering from gingival
infection and proven to be effective to induce inflam-
matory response [24–26]. For experiments in vitro, cells
were grown to a confluent state (90%). One hour prior to
stimulation, cells were adapted to a glycine-free medium
(SMEM, Supplemented Eagle’s Minimum Essential Medium,
GIBCO/Invitrogen, Darmstadt, Germany). For stimulation
experiments, cells were treated with 5 ng/mL IL-1𝛽 in the
presence or absence of glycine (5mM glycine). Following a
stimulation time of 30 or 60 minutes, cells were analyzed
for changes in gene expression of proinflammatory markers
IL6 and IL8. Preliminary experiments demonstrated a 30min
stimulation time for IL6 and 60min stimulation time for IL8
to be most effective for inflammatory response induction.
2.6. Glycine Stimulation Experiments. To analyze the possible
anti-inflammatory effect of glycine on gingiva keratinocytes,
in addition to the IL-1𝛽 conditioned medium, cells were
additionally stimulated with 5mM glycine (Sigma-Aldrich,
Taufkirchen, Germany) as demonstrated to be effective pre-
viously by Vardar-Sengul et al. [26]. For negative control,
glycine was administered alone.
2.7. Analyses of NF𝜅B Pathway Activation. To further char-
acterize pro- or anti-inflammatory effects of IL-1𝛽 with or
without glycine, activation of NF𝜅B pathway was investi-
gated. According to a protocol published previously [24],
gingival keratinocytes were stimulated for 6 h in combination
with IL-1𝛽with and without glycine as described above. After
incubation, cells were fixed and further analyzed for nuclear
translocation of p65 immune reactions using immune cyto-
chemistry with a primary antibody against NF𝜅B (BioLe-
gend, Uithoorn, Netherlands) in a 1 : 100 concentration [7].
The amount of cells showing positive immunoreactions
over the cell nucleus was assessed semiquantitatively by a
modification of the grading system published previously
[21]. The grading system was set up as follows: 0 = no
immune reaction in cell nucleus; 1 = 1/3 of the cell nucleus
demonstrated immune reactions; 2 = 2/3 of the cell nucleus
demonstrated immune reactions; 3 = immune reaction all
over the cell nucleus and the cytoplasm were visible; 4 =
immune reactivity was only located in cell nucleus. Cells were
counted in relation to total cell number at the investigated
region using AxioVision software (Carl Zeiss, Germany). To
ensure reproducibility, all counts were performed on four
independent experiments per stimulation group.
2.8. RNA Extraction and cDNA Synthesis. RNA was iso-
lated using the “RNeasy Protect Mini Kit” (Qiagen, Hilden,
Germany) and quantified using the NanoDrop ND-1000
Spectrophotometer (NanoDrop, Technologies, Wilmington,
USA). 1 𝜇g total RNAwas reversely transcribed using “iScript
Select cDNASynthesis Kit” (BioRad,Munich,Germany)with
oligo(dT)-primers [24].
2.9. Quantitative Real-Time PCR. Gene expression of 𝛽-
actin, IL6, and IL8 was analyzed by real-time PCR with
the iCycler Thermal Cycler (BioRad). SYBR Green served
as fluorophore for online monitoring of generated PCR
products as described previously [24]. In brief, all primers
were synthesized according to the highest quality standards
(Metabion, Martinsried, Germany) and verified by computer
analysis for specification (BLAST). Primer sequences are
presented in Table 1. Amplification for the detection of 𝛽-
actin was performed under the following conditions: 95∘C
for 5min followed by 40 cycles of 95∘C for 15 s, 69∘C for
30 s, and 72∘C for 30 s. IL6 and IL8 were amplified under
the same conditions except for the annealing temperature
which was set at 68∘C. 50 ng cDNA was added to a master
mix containing primers and IQ SYBR Green Supermix
(BioRad). The reference gene 𝛽-actin was used as standard
for normalizing the crossing point. Cloned PCR products
derived from the specific primers served as positive controls
for the PCR, while water was used as the negative control.
PCR was performed for all samples individually. Resulting
gene expressions were averaged. Relative differential gene
expression was calculated using the method described by
Pfaffl [27]. PCR efficiencies were determined with dilution
series as listed above (Table 2).
2.10. Immunofluorescence andCytochemistry. GECswere cul-
tured on sterile coverslips and grown to 90% of conflu-
ency. The cells were washed with phosphate-buffered saline
(PBS, PAA Laboratories, Co¨lbe, Germany), fixed with 4%
paraformaldehyde for 15min at room temperature, washed
with PBS, and permeabilized thereafter in 0.1% Triton X-100
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Table 1: Primer sequences for real-time PCR for 𝛽-actin, IL-6, and
IL-8.
Gene Primer sequence
𝛽-actin Sense 5
󸀠-CATGGATGATGATATCGCCGCG-3󸀠
Antisense 5󸀠-ACATGATCTGGGTCATCTTCTCG-3󸀠
IL-6 Sense 5
󸀠-ATGAACTCCTTCTCCACAAGC-3󸀠
Antisense 5󸀠-CTACATTTGCCGAAGAGCCC-3󸀠
IL-8 Sense 5
󸀠-ATGACTTCCAAGCTGGCCGTGG-3󸀠
Antisense 5󸀠-TGAATTCTCAGCCCTCTTCAAAAAC-3󸀠
Table 2: Primer efficiencies and corresponding annealing tempera-
tures for 𝛽-actin, IL-6, and IL-8.
Gene Efficiency Temperature (∘C)
𝛽-actin 1.84 69
IL-6 2.12 68
IL-8 2.02 68
in PBS for 10min. After washing with PBS, nonspecific bind-
ing was blocked by a 60min treatment in a 1% bovine serum
albumin solution (BSA; Sigma-Aldrich). Incubation with the
primary anti-glycine receptor antibody (SYSY, Go¨ttingen,
Germany, 1:250) was performed overnight at room temper-
ature. Following extensive washing, a Cy-3-conjugated anti-
rabbit IgG secondary antibody (Dianova, Hamburg, Ger-
many) was applied for 50min at room temperature. Finally,
cells were washed three times with PBS. Nuclear staining was
achieved by incubating the cells in DAPI for 8min, followed
by washing twice with Aqua dest. Cells were mounted
with Mowiol/DABCO (Roth, Karlsruhe, Germany) for flu-
orescence microscopic imaging using a Zeiss fluorescence
microscope (AXIO ImagerA1, Carl ZeissMicroImaging). For
cytochemistry, a horseradish-peroxidase- (HRP-) conjugated
secondary antibody (Dako Invision) was used instead and
cells were counterstained with hemalaun as described above.
2.11. Statistical Analysis. The PCR data are presented as
means ± SD of 10 independent experiments. Statistical
significant differences in means were assessed using one-
way analysis of variances (ANOVA) in GraphPad Prism
version 4.03 for Windows (Graph Pad Software, San Diego,
California, USA, http://www.graphpad.com/). A value of 𝑃 <
0.05 was considered statistically significant.
3. Results
3.1. Presence of the Glycine Receptor inHumanGingival Tissue.
Explants of human gingival tissue were analyzed for glycine
receptor expression by immunohistochemistry to investigate
whether glycine receptor is expressed in human gingival
tissue. The immune staining of healthy human gingival
tissue sections revealed a strong glycine receptor expression
within the epithelial layers of the gingiva tissue. Within the
investigated samples, glycine receptor immune reactivity was
mainly concentrated to gingival keratinocytes (Figures 1(a)
and 1(b)). At cellular level, positive immune reactions were
mainly located at both cell membranes and in the cytoplasm
of the cells. The underlying basal membrane of the gingiva
tissue as well as the other connective tissues showed no
positive immune reactions for the glycine receptor.
3.2. Demonstration of Glycine Receptor in Isolated Gingiva
Keratinocytes. In a second step, the aim was to verify the
observed in vivo findings of glycine receptor expression in
human gingival tissue sections in isolated human gingival
keratinocytes in order to provide the basis for further
experiments on those cells. Similar to the in vivo findings,
positive immune reactions for glycine receptor were also
found in cell cultures of isolated gingival keratinocytes. In
our experiments fourth passage gingival keratinocytes from
healthy humane donors demonstrated a significant amount
of immune reactions for glycine receptor expression mainly
located on the outer cell membrane and in the cell cytoplasm
(Figures 2(a), 2(b), and 2(c)).
3.3. Application of Isolated Challenge with IL-1𝛽. To mimic
an inflammatory impact on gingival keratinocytes similar to
conditions in oral gingivitis in patients, cells were cultured
in presence of the amount of IL-1𝛽 which was measured in
gingival inflamed patients previously [26]. Following IL-1𝛽
stimulation, an impact on mRNA expression of proinflam-
matorymarkers interleukin 6 and interleukin 8was observed.
Compared to untreated controls, themRNAexpression of IL6
was increased by 2.3-fold (Figure 3(a)) and IL8 expressionwas
upregulated by 3.5-fold (Figure 3(b)). Changes in IL6 and IL8
were demonstrated to be significant to control cultures.
3.4. Effect of Glycine on IL6 and IL8 mRNA Expression. In
addition to the IL-1𝛽 administration, cells were additionally
stimulated with glycine to analyze the anti-inflammatory
potential of glycine on induced gingival inflammatory con-
ditions. Following glycine administration, the expression of
the analyzed proinflammatory markers was demonstrated
to be downregulated. The observed inflammatory effect on
IL6 expression was significantly reduced compared to the
isolated IL-1𝛽 stimulation group (0.8- instead of 2.3-fold of
control; Figure 3(a)). The effect on IL8 mRNA expression
was also significantly reduced when glycine was added to
the conditioned cell culture medium (2.4- instead of 3.5-fold
of control (Figure 3(b)). Interestingly, isolated application of
glycine seems also to induce a slight upregulation of IL6 in
mRNA expression (Figure 3(a)). In combination with IL-1𝛽 a
downregulation was observed.
3.5. Effect of Glycine on NF𝜅B Pathway-Mediated Inflam-
matory Response. As a second approach, the immune-
modulatory effect of glycine on inflammatory signaling
pathway NF𝜅B using the NF𝜅B related protein p65 was
analyzed. In this context, changes were addressed for p65
protein expression which is localized in the cytoplasm in
noninflammatory conditions. In the present experiments,
p65 protein was demonstrated to be located in the cell cyto-
plasm of untreated human gingival keratinocytes (Figure 4).
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(a) (b)
Figure 1: Demonstration of the glycine receptor (GlyR) in gingival tissue. Overview (a) of oral tissue (magnification ×10) isolated
from extracted upper third molars showing different region of the gingival tissue (OG: oral gingival tissue; st: subepithelial tissue). (b)
Representative gingival tissue section (magnification ×200) assessed by immunohistochemistry using an anti-glycine receptor antibody
(SYSY, Go¨ttingen, Germany) at 4∘C overnight and counterstaining with DAB (brown color). There was strong immune reaction in the
epithelial layers of the gingiva, namely, in gingival keratinocytes. The underlying basal membrane as well as the connective tissue showed
negative immune staining.
(a) (b) (c)
Figure 2: Cytochemical ((a): negative control, (b): anti-glycine receptor) and immunofluorescence ((c) anti-glycine receptor) staining for
Glycine receptor in cultured human gingival keratinocytes (red color, black arrow). For nuclear staining, cells were treated with DAPI (blue
color, (c)).
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Figure 3: Effect of IL-1𝛽 and glycine treatment on the mRNA expression of the proinflammatory cytokines IL6 (a) and IL8 (b). Confluent
cultures of gingival keratinocytes were treated with IL-1𝛽 either alone or in combination with glycine to induce inflammatory conditions in
vitro. Glycine administration to inflammatory challenged gingival keratinocytes resulted in a decreased proinflammatory cytokine mRNA
expression of both IL6 (a) and IL8 (b). Results are presented as means ± SD (𝑛 = 10); ∗𝑃 < 0.05 difference between groups following ANOVA
analysis.
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Figure 4: Effects of IL-1𝛽 and/or glycine on NF𝜅B signaling. (a) Immune fluorescence staining of NF𝜅B signaling protein p65 of cells (A),
glycine (B), IL-1𝛽 (C), and IL-1𝛽 + glycine (D) treated human gingival keratinocytes. The photographs demonstrate a localization of p65
protein primarily in the cell cytoplasm in untreated cells. Untreated controls (A) and glycine treated cells (B) did not affect p65 expression.
Following the induction of inflammation by IL-1𝛽 administration, NF𝜅B pathway was activated as demonstrated by translocation of p65
protein to the cell nucleus (C).The addition of glycine to the inflammatory cell culturemedium reduced the observed p65 protein translocation
(D). (b) Semiquantitative assessment of p65 protein translocation in human gingival keratinocytes following administration of IL-1𝛽 in
combination with and without glycine. ∗𝑃 < 0.05 difference between treated and control groups following ANOVA analysis; #𝑃 < 0.05
difference between IL-1𝛽 and IL-1𝛽 + glycine treated groups.
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Following the induction of inflammation by stimulation
with IL-1𝛽, a pronounced accumulation of NF𝜅B in the cell
nucleus was observed. When glycine was added to the condi-
tioned cell culturemedium the inflammatory translocation of
p65 NF𝜅B pathway protein was almost completely abolished.
Similar to control experiments, p65 immune reactions were
mainly located in the cytoplasm of the cells and did not
translocate to the cell nucleus in glycine treated cell culture
experiments.
4. Discussion
To our knowledge, this study is the first which analyzes
the existence of the glycine receptor in gingival tissue and
gingival derived keratinocytes. Both, tissue sections of human
gingival tissue and human gingival keratinocytes demon-
strated a ubiquitous expression of the glycine receptor in the
gingival tissuewhichwasmainly located at the cellmembrane
and in the cytoplasmic region. Similar to present findings,
other authors documented similar findings on the location of
the glycine binding receptor (GlyR) in different cell systems.
For example, Webb and Lynch demonstrated in their studies
on neural cells that the glycine receptor was located on the
cell membrane which acts as a receptor with transmembrane
domains and extracellular binding sites as well as chloride-
sensitive transmembrane channels [28]. Similar to this report,
Zhong et al. [11] also demonstrated the GlyR as a membrane
receptor in “Kupffer” cells. On the other hand, Be´chade
[29] observed both a membrane and a more cytoplasmatic
localization of the GlyR in oligodendrocytes and in glia cells.
From the present findings the expression of GlyR both in
the membrane and within the cell cytoplasm in gingival
keratinocytes can be suggested.
To mimic the clinical situation of gingival inflammation
such as in conditions of oral gingival inflammation in the
present in vitro experiments, isolated gingival keratinocytes
were challenged with IL-1𝛽 at the amount being found to
be expressed in patients suffering from gingivitis [30]. The
used amount of interleukin 1𝛽 application has been proven
to be effective in the present findings as shown by the
upregulation of cytokine mRNA expression levels of IL6
and IL8 and the induction of NF𝜅B activation in treated
gingival keratinocytes. Steinberg et al. [7] and McKay and
Cidlowski [31] also reported similar effects of IL-1𝛽-induced
inflammation in their experiments on gingival keratinocytes
after stimulation with IL-1𝛽. Also the inflammatory response
of oral cells to cytokine application on protein level of
the investigated inflammatory parameters was proven in
previous experiments suggesting the effectiveness of the
present protocol [24, 32, 33]. A significant inflammatory
response of treated specimens was observed in this study
and also in reports from other authors. Corresponding to the
presented regulation of IL6 and IL8 mRNA expression, also
Kraus and coworkers [24] presented in a recent work that
bacterial LPS stimulation was able to show similar and even
stronger inflammatory responses of gingival keratinocytes
as documented in the present study. Again the present data
on IL-1𝛽 induced inflammation underline the efficiency and
capability of IL-𝛽 to induce inflammatory reactions.
The addition of glycine to the cell culture medium
of inflammatory challenged gingival keratinocytes demon-
strated the ability to attenuate the observed inflammatory
response of gingival keratinocytes. Since the standard Ker-
atinocyte Growth Medium (KGM) contains different amino
acids including glycine, we therefore analyzed its impact on
cell culture conditions by using also glycine-free medium in
preliminary unpublished experiments. Induction of different
inflammatory cytokines in keratinocytes was demonstrated
to be nearly identical compared to the used standardmedium
in these experiments. Therefore the described standard cell
culture medium was used in present experiments.
Interestingly an initial upregulation of the mRNA expres-
sion of the investigated early inflammatory marker IL6, but
not IL8, after 30min of stimulation with glycine alone was
observed. A possible explanation for this regulation might be
due to an early cellular response to changes within the cell
culture medium by the application of glycine. Interestingly
in combination with IL-1𝛽 protein this upregulation was
inhibited. The regulation of IL8 expression, which is known
as a more stable inflammatory marker, was not affected by
glycine application. After adding glycine to the cytokine con-
taminated medium, a significant inhibition of the immediate
upregulation of the cytokines IL6 and IL8 at the transcrip-
tional level and a decrease in p65 nuclear translocation were
observed. This glycine-induced anti-inflammatory response
goes hand in hand with reports of others on observations in
several different cell and organ systems. In his recent review
article Zhong and coworkers [11] pointed to the observed
anti-inflammatory potential of glycine. They reported that
glycine is found to be protective under several inflammatory
conditions such as shock, endotoxin, and sepsis and to
prevent ischemia-reperfusion injury to a variety of tissues and
organs including liver, kidney, heart, intestine, and skeletal
muscle. Furthermore, glycine also protected against pepti-
doglycan polysaccharide-induced arthritis and protects the
gastricmucosa against chemical and stress-induced ulcers. In
their review these authors concluded that glycine appears to
exert several protective effects, including anti-inflammatory,
immune-modulatory, and direct cytoprotective actions [11].
Furthermore it has been suggested that glycine is also able to
act on inflammatory cells such as macrophages to suppress
activation of inflammatory transcription factors and the
formation of free radicals and inflammatory cytokines. In
the light of the findings in the present investigation and the
reported effects of glycine in the literature, it can be suggested
that also gingival tissue with special regard to gingival
keratinocytes is able to perform a glycine-mediated anti-
inflammatory response under inflammatory circumstances.
5. Conclusions
In conclusion, the present data demonstrate at first that the
glycine receptor is expressed in gingival tissue and indicates
an immune-regulatory role for glycine in the response of
gingival keratinocytes to inflammatory conditions. Together
with recent reports about glycine physiology, the modula-
tory potential of glycine within the inflammatory process
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in gingival tissue becomes obvious. The mapping of inter-
cellular cytokine signaling networks and its modulating
reagents, with special regard to glycine that functionally
couples gingival tissues, and its activation to induce immune
response may also provide information for future potential
clinical targets. This could include the prevention of severe
gingivitis and the further development of periodontal disease
which is discussed to be the result of long lasting gingival
inflammation. Furthermore, the immune-modulatory role
of glycine in the course of gingival inflammation extends
the well accepted knowledge of anti-inflammatory effects of
glycine in the oral gingival tissue that again points to glycine
as a promising treatment agent in inflammatory conditions.
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